Lataa...
Integrated safety and efficacy analysis of once-daily fluticasone furoate for the treatment of asthma
BACKGROUND: Fluticasone furoate is a once-daily inhaled corticosteroid. This report provides an overview of safety and efficacy data that support the use of once-daily fluticasone furoate 100 μg or 200 μg in adult and adolescent asthma patients. METHODS: Fourteen clinical studies (six Phase II and e...
Tallennettuna:
| Julkaisussa: | Respir Res |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5122018/ https://ncbi.nlm.nih.gov/pubmed/27881132 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-016-0473-x |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|